Genomic analyses implicate noncoding de novo variants in congenital heart disease

Journal: Nature Genetics

Published: 2020-06-29

DOI: 10.1038/s41588-020-0652-z

Affiliations: 31

Authors: 35

Go to article
Institutions Share
Harvard University, United States of America (USA) 0.21
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA) 0.10
USTAR Center for Genetic Discovery, United States of America (USA) 0.09
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA) 0.07
Flatiron Institute, Simons Foundation, United States of America (USA) 0.05
Boston Children's Hospital (BCH), United States of America (USA) 0.04
Department of Genetics and Genomic Sciences, ISMMS, United States of America (USA) 0.04
Yale University, United States of America (USA) 0.03
Lawrence Berkeley National Laboratory (LBNL), United States of America (USA) 0.03
Health Sciences Center (HSC), Utah, United States of America (USA) 0.03
University of California, San Francisco (UCSF), United States of America (USA) 0.03
Stanford University, United States of America (USA) 0.03
University of Rochester Medical Center (URMC), UR, United States of America (USA) 0.03
USC Children's Hospital Los Angeles (CHLA), United States of America (USA) 0.03
Great Ormond Street Hospital for Children (GOSH), United Kingdom (UK) 0.03
NIH National Heart, Lung, and Blood Institute (NHLBI), United States of America (USA) 0.03
Princeton University, United States of America (USA) 0.03
Sema4, Inc., United States of America (USA) 0.02
Brigham and Women's Hospital (BWH), United States of America (USA) 0.02
University of Pennsylvania (Penn), United States of America (USA) 0.01
Children's Hospital of Philadelphia (CHOP), United States of America (USA) 0.01
Gladstone Institutes, United States of America (USA) 0.01
Takeda Pharmaceuticals U.S.A., Inc., United States of America (USA) 0.01
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA) 0.01

Return